NASDAQ: VTRS
Viatris Inc Stock Ownership - Who owns Viatris?

Insider buying vs selling

Have Viatris Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Goff Corinne LeChief Commercial Officer2025-09-117,032$10.25
$72.04kSell
Scott Andrew SmithChief Executive Officer2025-08-1222,000$9.99
$219.74kBuy
Scott Andrew SmithChief Executive Officer2025-05-1260,000$8.94
$536.28kBuy
Goff Corinne LeChief Commercial Officer2025-04-1519,023$7.48
$142.29kSell
Goff Corinne LeChief Commercial Officer2025-04-15855$7.48
$6.40kSell
Paul CampbellChief Accounting Officer and Corporate Controller2025-03-0474,110$9.37
$694.41kSell
Leo Frans GroothuisDirector2025-03-041,166$9.37
$10.93kSell
Leo Frans GroothuisDirector2025-03-0450$9.37
$468.50Sell
Goff Corinne LeChief Commercial Officer2025-03-0416,276$9.37
$152.51kSell
Goff Corinne LeChief Commercial Officer2025-03-04521$9.37
$4.88kSell

1 of 4

VTRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTRS insiders and whales buy or sell their stock.

VTRS Shareholders

What type of owners hold Viatris Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.18%140,273,202$1.50BInstitution
Laboratories Abbott11.79%135,750,000$1.46BInsider
Price T Rowe Associates Inc7.30%84,064,766$901.17MInstitution
Blackrock Inc7.12%81,959,740$878.61MInstitution
Davis Selected Advisers6.02%69,345,645$743.39MInstitution
Products Abbott5.45%62,782,018$673.02MInsider
State Street Corp4.84%55,707,362$597.18MInstitution
Dimensional Fund Advisors LP3.24%37,370,338$400.61MInstitution
Geode Capital Management LLC2.60%29,916,495$320.70MInstitution
Ameriprise Financial Inc2.42%27,822,902$298.26MInstitution

1 of 3

VTRS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTRS81.73%18.27%Net SellingNet Selling
RDY12.80%0.00%
ELAN91.70%8.30%Net Selling
NBIX70.42%29.58%Net SellingNet Selling
RGC0.13%0.00%

Viatris Stock Ownership FAQ

Who owns Viatris?

Viatris (NASDAQ: VTRS) is owned by 82.74% institutional shareholders, 18.50% Viatris insiders, and 0.00% retail investors. Laboratories Abbott is the largest individual Viatris shareholder, owning 135.75M shares representing 11.79% of the company. Laboratories Abbott's Viatris shares are currently valued at $1.46B.

If you're new to stock investing, here's how to buy Viatris stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.